Impact of denosumab use on the survival of untreated non-squamous non-small cell lung cancer patients with bone metastases

ConclusionsOur results suggest that treatment with denosumab may improve the overall survival of non-squamous NSCLC patients with BM.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research